Medizone Home
×
International Pharma Supplies Analytical Samples for Biosimilar Development Unlicensed Medicines Supplies Comparator Sourcing for clinical trials

International Pharma Supplies

We supply prescription only and OTC products to authorized wholesalers, licensed importers and aid organisations – from anywhere in the EU with a focus on German products.

Analytical Samples for Biosimilar Development

We supply analytical samples for Biosimilar development from almost anywhere in the world – Multi-country, Multi-batch and Multi-expiry date approach.

Unlicensed Medicines Supplies

We supply prescription only and OTC products to companies that have specialized in unlicensed medicines supplies, government agencies, hospitals and pharmacies.

Comparator Sourcing for clinical trials

We source Comparator products from almost anywhere in the World and have direct access to many innovators and approved supply sources.

Samsung Bioepis first to receive EC approval for its third anti-TNF biosimilar

Samsung Bioepis Co., Ltd. last week announced the European Commission’s (EC) approval of Imraldi, a biosimilar referencing Humira (adalimumab). Imraldi is approved for the treatment of rheumatoid ...

Meet us at our booth at expopharm 2017 – 13th to 16th September

We are looking forward to welcoming you at our booth at expopharm 2017 - 13th to 16th September Medizone - Hall 5 - Booth A23 For more information visit expopharm exhibitor ...

FDA rejects Coherus’ biosimilar application for Amgen’s Neulasta

Coherus BioSciences, Inc., announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) for its biologics license application for CHS-1701, a pegfilgrastim (Neulasta) ...

Sandoz gains EU approval for biosimilar version of Roche’s MabThera

Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced that the European Commission (EC) has approved Rixathon (biosimilar rituximab) for use in Europe. Rixathon is ...
Pages:12»